Irf8 functions as a leukemia suppressor for chronic myeloid leukemia, and young Irf8−/− mice have neutrophilia with progression to acute myeloid leukemia (AML) with aging. Here, IRF8 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.